Antibody Market - Global Outlook and Forecast 2021-2027
Report Code: KNJ759871 No. of Pages: 100 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
The Antibody market report provides the overall market analysis of the industry. This market report presents the current snapshot of the Antibody market to understand the market's key features. The content of the report highlights the important market criteria that help to develop the market further. The report provides the value and the volume of the Antibody at global, regional, and company levels. The historical market value for the year 2021 along with the market value for the upcoming year 2027 has been presented in the market report. Along with that, the report also provides information on subjects such as Export, import, production, and production capacity of the Antibody market.This report contains market size and forecasts of Antibody in global, including the following market information: Global Antibody Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Antibody Market Sales, 2016-2021, 2022-2027, (MT) Global top five Antibody companies in 2020 (%) The global Antibody market was valued at 8884.3 million in 2020 and is projected to reach US$ 10830 million by 2027, at a CAGR of 5.1% during the forecast period. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Antibody Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT) Global Antibody Market Segment Percentages, By Type, 2020 (%) IgM IgG IgA Other Global Antibody Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT) Global Antibody Market Segment Percentages, By Application, 2020 (%) Therapeutic Research Diagnostic Global Antibody Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT) Global Antibody Market Segment Percentages, By Region and Country, 2020 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Antibody revenues in global market, 2016-2021 (Estimated), ($ millions) Key companies Antibody revenues share in global market, 2020 (%) Key companies Antibody sales in global market, 2016-2021 (Estimated), (MT) Key companies Antibody sales share in global market, 2020 (%) Further, the report presents profiles of competitors in the market, key players include: Roche Johnson & Johnson Merck Novartis AbbVie Amgen Pfizer Bayer Lilly Bristol-Myers Squibb GlaxoSmithKline Biogen AstraZeneca Sanofi Alexion Pharmaceuticals Seattle Genetics
1 Introduction to Research & Analysis Reports
1.1 Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antibody Overall Market Size
2.1 Global Antibody Market Size: 2021 VS 2027
2.2 Global Antibody Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Antibody Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Antibody Players in Global Market
3.2 Top Global Antibody Companies Ranked by Revenue
3.3 Global Antibody Revenue by Companies
3.4 Global Antibody Sales by Companies
3.5 Global Antibody Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antibody Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibody Players in Global Market
3.8.1 List of Global Tier 1 Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Antibody Market Size Markets, 2021 & 2027
4.1.2 IgM
4.1.3 IgG
4.1.4 IgA
4.1.5 Other
4.2 By Type - Global Antibody Revenue & Forecasts
4.2.1 By Type - Global Antibody Revenue, 2016-2021
4.2.2 By Type - Global Antibody Revenue, 2022-2027
4.2.3 By Type - Global Antibody Revenue Market Share, 2016-2027
4.3 By Type - Global Antibody Sales & Forecasts
4.3.1 By Type - Global Antibody Sales, 2016-2021
4.3.2 By Type - Global Antibody Sales, 2022-2027
4.3.3 By Type - Global Antibody Sales Market Share, 2016-2027
4.4 By Type - Global Antibody Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antibody Market Size, 2021 & 2027
5.1.2 Therapeutic
5.1.3 Research
5.1.4 Diagnostic
5.2 By Application - Global Antibody Revenue & Forecasts
5.2.1 By Application - Global Antibody Revenue, 2016-2021
5.2.2 By Application - Global Antibody Revenue, 2022-2027
5.2.3 By Application - Global Antibody Revenue Market Share, 2016-2027
5.3 By Application - Global Antibody Sales & Forecasts
5.3.1 By Application - Global Antibody Sales, 2016-2021
5.3.2 By Application - Global Antibody Sales, 2022-2027
5.3.3 By Application - Global Antibody Sales Market Share, 2016-2027
5.4 By Application - Global Antibody Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Antibody Market Size, 2021 & 2027
6.2 By Region - Global Antibody Revenue & Forecasts
6.2.1 By Region - Global Antibody Revenue, 2016-2021
6.2.2 By Region - Global Antibody Revenue, 2022-2027
6.2.3 By Region - Global Antibody Revenue Market Share, 2016-2027
6.3 By Region - Global Antibody Sales & Forecasts
6.3.1 By Region - Global Antibody Sales, 2016-2021
6.3.2 By Region - Global Antibody Sales, 2022-2027
6.3.3 By Region - Global Antibody Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Antibody Revenue, 2016-2027
6.4.2 By Country - North America Antibody Sales, 2016-2027
6.4.3 US Antibody Market Size, 2016-2027
6.4.4 Canada Antibody Market Size, 2016-2027
6.4.5 Mexico Antibody Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Antibody Revenue, 2016-2027
6.5.2 By Country - Europe Antibody Sales, 2016-2027
6.5.3 Germany Antibody Market Size, 2016-2027
6.5.4 France Antibody Market Size, 2016-2027
6.5.5 U.K. Antibody Market Size, 2016-2027
6.5.6 Italy Antibody Market Size, 2016-2027
6.5.7 Russia Antibody Market Size, 2016-2027
6.5.8 Nordic Countries Antibody Market Size, 2016-2027
6.5.9 Benelux Antibody Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Antibody Revenue, 2016-2027
6.6.2 By Region - Asia Antibody Sales, 2016-2027
6.6.3 China Antibody Market Size, 2016-2027
6.6.4 Japan Antibody Market Size, 2016-2027
6.6.5 South Korea Antibody Market Size, 2016-2027
6.6.6 Southeast Asia Antibody Market Size, 2016-2027
6.6.7 India Antibody Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Antibody Revenue, 2016-2027
6.7.2 By Country - South America Antibody Sales, 2016-2027
6.7.3 Brazil Antibody Market Size, 2016-2027
6.7.4 Argentina Antibody Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antibody Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Antibody Sales, 2016-2027
6.8.3 Turkey Antibody Market Size, 2016-2027
6.8.4 Israel Antibody Market Size, 2016-2027
6.8.5 Saudi Arabia Antibody Market Size, 2016-2027
6.8.6 UAE Antibody Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Antibody Major Product Offerings
7.1.4 Roche Antibody Sales and Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Antibody Major Product Offerings
7.2.4 Johnson & Johnson Antibody Sales and Revenue in Global (2016-2021)
7.2.5 Johnson & Johnson Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Antibody Major Product Offerings
7.3.4 Merck Antibody Sales and Revenue in Global (2016-2021)
7.3.5 Merck Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Antibody Major Product Offerings
7.4.4 Novartis Antibody Sales and Revenue in Global (2016-2021)
7.4.5 Novartis Key News
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Antibody Major Product Offerings
7.5.4 AbbVie Antibody Sales and Revenue in Global (2016-2021)
7.5.5 AbbVie Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Antibody Major Product Offerings
7.6.4 Amgen Antibody Sales and Revenue in Global (2016-2021)
7.6.5 Amgen Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Antibody Major Product Offerings
7.4.4 Pfizer Antibody Sales and Revenue in Global (2016-2021)
7.7.5 Pfizer Key News
7.8 Bayer
7.8.1 Bayer Corporate Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Antibody Major Product Offerings
7.8.4 Bayer Antibody Sales and Revenue in Global (2016-2021)
7.8.5 Bayer Key News
7.9 Lilly
7.9.1 Lilly Corporate Summary
7.9.2 Lilly Business Overview
7.9.3 Lilly Antibody Major Product Offerings
7.9.4 Lilly Antibody Sales and Revenue in Global (2016-2021)
7.9.5 Lilly Key News
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Corporate Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Antibody Major Product Offerings
7.10.4 Bristol-Myers Squibb Antibody Sales and Revenue in Global (2016-2021)
7.10.5 Bristol-Myers Squibb Key News
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Corporate Summary
7.11.2 GlaxoSmithKline Antibody Business Overview
7.11.3 GlaxoSmithKline Antibody Major Product Offerings
7.11.4 GlaxoSmithKline Antibody Sales and Revenue in Global (2016-2021)
7.11.5 GlaxoSmithKline Key News
7.12 Biogen
7.12.1 Biogen Corporate Summary
7.12.2 Biogen Antibody Business Overview
7.12.3 Biogen Antibody Major Product Offerings
7.12.4 Biogen Antibody Sales and Revenue in Global (2016-2021)
7.12.5 Biogen Key News
7.13 AstraZeneca
7.13.1 AstraZeneca Corporate Summary
7.13.2 AstraZeneca Antibody Business Overview
7.13.3 AstraZeneca Antibody Major Product Offerings
7.13.4 AstraZeneca Antibody Sales and Revenue in Global (2016-2021)
7.13.5 AstraZeneca Key News
7.14 Sanofi
7.14.1 Sanofi Corporate Summary
7.14.2 Sanofi Business Overview
7.14.3 Sanofi Antibody Major Product Offerings
7.14.4 Sanofi Antibody Sales and Revenue in Global (2016-2021)
7.14.5 Sanofi Key News
7.15 Alexion Pharmaceuticals
7.15.1 Alexion Pharmaceuticals Corporate Summary
7.15.2 Alexion Pharmaceuticals Business Overview
7.15.3 Alexion Pharmaceuticals Antibody Major Product Offerings
7.15.4 Alexion Pharmaceuticals Antibody Sales and Revenue in Global (2016-2021)
7.15.5 Alexion Pharmaceuticals Key News
7.16 Seattle Genetics
7.16.1 Seattle Genetics Corporate Summary
7.16.2 Seattle Genetics Business Overview
7.16.3 Seattle Genetics Antibody Major Product Offerings
7.16.4 Seattle Genetics Antibody Sales and Revenue in Global (2016-2021)
7.16.5 Seattle Genetics Key News
8 Global Antibody Production Capacity, Analysis
8.1 Global Antibody Production Capacity, 2016-2027
8.2 Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global Antibody Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antibody Supply Chain Analysis
10.1 Antibody Industry Value Chain
10.2 Antibody Upstream Market
10.3 Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antibody Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com